May 3, 2017
Japan Times (May 3, 2017): In Tests Across Japan, New Tech Allows Speedy Tracking of Lost Dementia Patients
Japan’s rapidly aging society is spurring technological innovation, including the use of a tracking system designed to help families and nursing facilities locate people suffering from dementia when they lose their way or go missing.
As the country with the most aged population, Japan is poised to see its postwar baby-boomer generation — currently the biggest age demographic — form a population stratum aged 75 or older by 2025.
May 3, 2017
A habitually healthy eater, Frank Hu stocks his refrigerator with fresh fruits and vegetables, fish, and chicken. His pantry holds brown rice, whole grains, and legumes, and his snack cabinet has nuts and seeds. He eats red meat only occasionally, rarely buys white bread, soda, bacon, or other processed meats. He’ll purchase chips and beer, but only now and then, mostly when entertaining friends.
When it comes to eating smartly in ways that can help us keep fit and live longer, Hu knows best.
April 28, 2017
University of Zurich Dies Academicus (April 29, 2017) Festivities: Congratulations to Dr. John H. Growdon!
Congraulations to the Massachusetts Alzheimer's Disease Research Center's Founding Director - John H. Growdon, MD - on his honorary doctorate from the University of Zurich!
April 28, 2017
The brain and how it learns may be among the most complicated puzzles in the quickly advancing field of neuroscience. But Harvard is trying to unravel its mystery.
April 26, 2017
The morning light is pouring into the senior living community in Canton, where six residents are performing an exquisite choreography of sweeping, lyrical movements, emulating their Tai chi instructor.
“Wave hands like clouds,” urges Kerry Paulhus, leading them in the classic low-impact and slow-motion exercises of the ancient Chinese martial art. With relaxing music playing in the background, the students shift their weight from one leg to the other, turn their waists, and rotate their arms as if they indeed were clouds.
April 26, 2017
Zoran Popović knows a thing or two about video games. A computer science professor at the University of Washington, Dr. Popović has worked on software algorithms that make computer-controlled characters move realistically in games like the science-fiction shooter “Destiny.”
April 24, 2017
Earlier in his career, Paul Bolno worked with neuroscientists at drug giant GlaxoSmithKline PLC. Today, as chief executive of Wave Life Sciences Ltd., he is leading the Cambridge biotech’s effort to advance two experimental drugs that could become the first treatments for the progressive brain disorder Huntington’s disease.
April 19, 2017
Alzheimer's Association (April 12, 2017): FDA Approves At-Home Test for an Alzheimer’s Disease Risk Gene: What You Need to Know
Perhaps your grandmother had Alzheimer’s disease; maybe your mom or dad is currently living with the disease. You may be concerned that you are seeing signs of the disease in yourself or a loved one. Whatever the situation, if your family has been touched by Alzheimer’s, it is natural to be curious if a genetic test is valuable in predicting the likelihood of developing the disease.
April 18, 2017
“If only,” wrote an ancient Japanese poet, “when one heard that Old Age was coming one could bolt the door….”
Science is working on it.
Aging is as much about the physical processes of repair and regeneration — and their slow-motion failure — as it is the passage of time. And scientists studying stem cell and regenerative biology are making progress understanding those processes, developing treatments for the many diseases whose risks increase as we get older, while at times seeming to draw close to a broader anti-aging breakthrough.
April 17, 2017
In one of the largest studies of its type, researchers confirm a link between midlife vascular disease and late-life dementia. As reported in the April 11 Journal of the American Medical Association, 50-year-olds with two or more vascular risk factors were almost three times more likely to have amyloid in the brain in their 70s as were those with no signs of cardiovascular disease in middle age. Researchers said that the study, led by Rebecca Gottesman at Johns Hopkins University School of Medicine, Baltimore, was impressive for the number of subjects and its prospective design.